BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8991744)

  • 1. Income class and pharmaceutical expenditure in Canada: 1964-1990.
    Lexchin J
    Can J Public Health; 1996; 87(1):46-50. PubMed ID: 8991744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.
    Alan S; Crossley TF; Grootendorst P; Veall MR
    J Health Econ; 2002 Sep; 21(5):805-26. PubMed ID: 12349883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordability.
    Lee JA; McKercher PL
    Clin Ther; 2002 Jun; 24(6):1003-16; discussion 1002. PubMed ID: 12117076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Out-of-pocket health care expenditures among population groups in Iceland].
    Vilhjálmsson R
    Laeknabladid; 2009 Oct; 95(10):661-8. PubMed ID: 19858545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medication supply of privately insured patients in 2010].
    Wild F
    Versicherungsmedizin; 2012 Jun; 64(2):85-6. PubMed ID: 22808648
    [No Abstract]   [Full Text] [Related]  

  • 7. Household spending on health care.
    Chaplin R; Earl L
    Health Rep; 2000 Oct; 12(1):57-65 (Eng); 61-70 (Fre). PubMed ID: 11565114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policy choice or economic fundamentals: what drives the public-private health expenditure balance in Canada?
    Di Matteo L
    Health Econ Policy Law; 2009 Jan; 4(Pt 1):29-53. PubMed ID: 19099616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmaceutical cost of elderly people in private health insurance].
    Wild F
    Versicherungsmedizin; 2009 Dec; 61(4):159-62. PubMed ID: 20052826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures.
    Demers V; Melo M; Jackevicius C; Cox J; Kalavrouziotis D; Rinfret S; Humphries KH; Johansen H; Tu JV; Pilote L
    CMAJ; 2008 Feb; 178(4):405-9. PubMed ID: 18268266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time.
    Di Matteo L
    Health Policy; 2005 Jan; 71(1):23-42. PubMed ID: 15563991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug costs in Canada.
    Fuller S
    Health Aff (Millwood); 2003; 22(4):259. PubMed ID: 12889774
    [No Abstract]   [Full Text] [Related]  

  • 13. Trends in out-of-pocket health care expenditures in Canada, by household income, 1997 to 2009.
    Sanmartin C; Hennessy D; Lu Y; Law MR
    Health Rep; 2014 Apr; 25(4):13-7. PubMed ID: 24744043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug policy down under: Australia's pharmaceutical benefits scheme.
    Duckett SJ
    Health Care Financ Rev; 2004; 25(3):55-67. PubMed ID: 15229996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of health care financing on family budgets.
    Rasell E; Bernstein J; Tang K
    Int J Health Serv; 1994; 24(4):691-714. PubMed ID: 7896470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding Canadian Medicare to include a national pharmaceutical benefit while controlling expenditures: possible lessons from Israel.
    Rosen B
    Health Econ Policy Law; 2018 Jul; 13(3-4):323-343. PubMed ID: 29400645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-provincial variation in government drug formularies.
    Grégoire JP; MacNeil P; Skilton K; Moisan J; Menon D; Jacobs P; McKenzie E; Ferguson B
    Can J Public Health; 2001; 92(4):307-12. PubMed ID: 11962119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical expenditure, total health-care expenditure and GDP.
    Clemente J; Marcuello C; Montañés A
    Health Econ; 2008 Oct; 17(10):1187-206. PubMed ID: 18050150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plans confront specialty pharmacy's escalating costs in variety of ways.
    Reinke T
    Manag Care; 2010 Dec; 19(12):12-3, 15-6, 19. PubMed ID: 21291126
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.